ArticleFrontiers in immunology2023

Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.

B Leticia Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.